BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
J Kumar Infraproject Ltd.’s results were above estimates, however Ebitda margin in line.
J Kumar Infra posted 13.8%/ 15.3%/ 17.6% YoY growth in revenue/ Ebitda/ adjusted profit after tax to Rs 11.3 billion/ Rs 1.6 billion / Rs 728 million in Q1 FY24. Ebitda margin up 19 basis points YoY to 14.3% primarily led by lower raw material cost, slightly negated by higher employee cost and other expenses.
We like J Kumar Infra due to robust order book of Rs 184.5 billion (4.3 times trailing twelve months revenue) coupled with huge opportunities in metro, urban infra, water and building segments.
J Kumar Infra has five-year vision of Rs 75 billion plus revenue (14-16% compound annual growth rate) and Rs 200 billion plus order book by FY27 providing sustainable growth.
Given the increased revenue visibility led by robust order inflow, we maintain 'Buy' with a revised target price of Rs 509 (10 times FY25E EPS versus eight times earlier).
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU
.jpeg?rect=0%2C0%2C3500%2C1969&w=75)
'Buy' JSW Infra Shares Maintains Motilal Oswal On Strong Balance Sheet, Favorable Macro


Multibagger Stock J Kumar Infra Sees Nearly 700% Returns Over Five Years — Should You Buy, Sell Or Hold?


Bondada Engineering Eyes Rs 4,000-Crore Revenue By FY27


DLF, Dixon, Zydus Lifesciences, Petronet LNG, Torrent Pharma, Quess Corp, IRB Infra, Karur Vysya Q4 Review
